Current anti-diabetes drugs are mainly aimed to correct hyperglycemia by promoting pancreatic β-cell insulin secretion, increasing insulin sensitivity, or reducing intestinal glucose uptake and hepatic gluconeogenesis. The gene discussed is INS; the disease is Hyperglycemia.